BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18053453)

  • 1. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
    Landgren O; Katzmann JA; Hsing AW; Pfeiffer RM; Kyle RA; Yeboah ED; Biritwum RB; Tettey Y; Adjei AA; Larson DR; Dispenzieri A; Melton LJ; Goldin LR; McMaster ML; Caporaso NE; Rajkumar SV
    Mayo Clin Proc; 2007 Dec; 82(12):1468-73. PubMed ID: 18053453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study.
    Landgren O; Kyle RA; Hoppin JA; Beane Freeman LE; Cerhan JR; Katzmann JA; Rajkumar SV; Alavanja MC
    Blood; 2009 Jun; 113(25):6386-91. PubMed ID: 19387005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
    N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men.
    Cicero KI; Joffe M; Patel M; Chiuzan C; Pentz A; Ruff P; Lentzsch S; Leng S; Jacobson JS; Rebbeck TR; Neugut AI
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2192-2198. PubMed ID: 36126958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.
    Landgren O; Gridley G; Turesson I; Caporaso NE; Goldin LR; Baris D; Fears TR; Hoover RN; Linet MS
    Blood; 2006 Feb; 107(3):904-6. PubMed ID: 16210333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.
    Landgren O; Zeig-Owens R; Giricz O; Goldfarb D; Murata K; Thoren K; Ramanathan L; Hultcrantz M; Dogan A; Nwankwo G; Steidl U; Pradhan K; Hall CB; Cohen HW; Jaber N; Schwartz T; Crowley L; Crane M; Irby S; Webber MP; Verma A; Prezant DJ
    JAMA Oncol; 2018 Jun; 4(6):821-827. PubMed ID: 29710195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.
    Landgren O; Rajkumar SV; Pfeiffer RM; Kyle RA; Katzmann JA; Dispenzieri A; Cai Q; Goldin LR; Caporaso NE; Fraumeni JF; Blot WJ; Signorello LB
    Blood; 2010 Aug; 116(7):1056-9. PubMed ID: 20421448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.
    Weiss BM; Minter A; Abadie J; Howard R; Ascencao J; Schechter GP; Kuehl M; Landgren O
    Am J Hematol; 2011 Jun; 86(6):475-8. PubMed ID: 21544856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
    Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
    Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection.
    Konstantinopoulos PA; Pantanowitz L; Dezube BJ
    J Natl Med Assoc; 2006 Nov; 98(11):1860-1. PubMed ID: 17128699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting.
    Singh J; Dudley AW; Kulig KA
    J Lab Clin Med; 1990 Dec; 116(6):785-9. PubMed ID: 2246554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.
    Wadhera RK; Rajkumar SV
    Mayo Clin Proc; 2010 Oct; 85(10):933-42. PubMed ID: 20713974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.
    Landgren O; Graubard BI; Katzmann JA; Kyle RA; Ahmadizadeh I; Clark R; Kumar SK; Dispenzieri A; Greenberg AJ; Therneau TM; Melton LJ; Caporaso N; Korde N; Roschewski M; Costello R; McQuillan GM; Rajkumar SV
    Leukemia; 2014 Jul; 28(7):1537-42. PubMed ID: 24441287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.
    Iwanaga M; Tagawa M; Tsukasaki K; Kamihira S; Tomonaga M
    Mayo Clin Proc; 2007 Dec; 82(12):1474-9. PubMed ID: 18053454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.
    Greenberg AJ; Vachon CM; Rajkumar SV
    Leukemia; 2012 Apr; 26(4):609-14. PubMed ID: 22193966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.
    Bida JP; Kyle RA; Therneau TM; Melton LJ; Plevak MF; Larson DR; Dispenzieri A; Katzmann JA; Rajkumar SV
    Mayo Clin Proc; 2009 Aug; 84(8):685-93. PubMed ID: 19648385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.
    Buadi F; Hsing AW; Katzmann JA; Pfeiffer RM; Waxman A; Yeboah ED; Biritwum RB; Tettey Y; Adjei A; Chu LW; DeMarzo A; Netto GJ; Dispenzieri A; Kyle RA; Rajkumar SV; Landgren O
    Am J Hematol; 2011 Jul; 86(7):554-8. PubMed ID: 21674575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis.
    Landgren O; Weiss BM
    Leukemia; 2009 Oct; 23(10):1691-7. PubMed ID: 19587704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.